Role of neuroimaging in the presurgical evaluation of epilepsy

Journal of Clinical Neurology (Korea)

Volumn 4, Issue 1, 2008, Pages 1-16

  Wehner, Tim ^a   Lüders, Hans ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Epilepsy; MRI; PET; SPECT; Surgery

Indexed keywords

EID: 73449114707     PISSN: 17386586     EISSN: 20055013     Source Type: Journal    
DOI: 10.3988/jcn.2008.4.1.1     Document Type: Review

References (94)

1. Rosenow F, Luders H. Presurgical evaluation of epilepsy. Brain 2001;124:1683-1700.
2. Engel J. Surgery for seizures. N Engl J Med 1996; 334:647-652.
3. Wiebe S, Blume WT, Girvin JP, Eliasziw M, Effectiveness and Efficiency of Surgery for Temporal Lobe Epilepsy Study Group. A randomized, controlled trial of surgery for temporal-lobe epilepsy. N Engl J Med 2001;345:311-318.
4. Raybaud C, Shroff M, Rutka JT, Chuang SH. Imaging surgical epilepsy in children. Childs Nerv Syst 2006; 22:786-809.
5. Koepp MJ, Woermann FG. Imaging structure and function in refractory focal epilepsy. Lancet Neurol 2005;4:42-53.
6. Cardoso TA, Coan AC, Kobayashi E, Guerreiro CA, Li LM, Cendes F. Hippocampal abnormalities and seizure recurrence after antiepileptic drug withdrawal. Neurology 2006;67:134-136.
7. Spooner CG, Berkovic SF, Mitchell LA, Wrennall JA, Harvey AS. New-onset temporal lobe epilepsy in children: Lesion on MRI predicts poor seizure outcome. Neurology 2006;67:2147-2153.
8. Berkovic SF, McIntosh AM, Kalnins RM, Jackson GD, Fabinyi GC, Brazenor GA, et al. Preoperative MRI predicts outcome of temporal lobectomy: An actuarial analysis. Neurology 1995;45:1358-1363.
9. Jeha LE, Najm I, Bingaman W, Dinner D, Widdess-Walsh P, Luders H. Surgical outcome and prognostic factors of frontal lobe epilepsy surgery. Brain 2007;130: 574-584.
10. Beaumont A, Whittle IR. The pathogenesis of tumour associated epilepsy. Acta Neurochir (Wien) 2000;142:1-15.
11. Krumholz A, Wiebe S, Gronseth G, Shinnar S, Levisohn P, Ting T, et al. Practice parameter: Evaluating an apparent unprovoked first seizure in adults (an evidence-based review): Report of the quality standards subcommittee of the american academy of neurology and the american epilepsy society. Neurology 2007;69:1996-2007.
12. ACEP Clinical Policies Committee, Clinical Policies Subcommittee on Seizures. Clinical policy: Critical issues in the evaluation and management of adult patients presenting to the emergency department with seizures. Ann Emerg Med 2004;43:605-625.
13. Recommendations for neuroimaging of patients with epilepsy. Commission on neuroimaging of the international league against epilepsy. Epilepsia 1997;38:1255-1256.
14. Guidelines for neuroimaging evaluation of patients with uncontrolled epilepsy considered for surgery. Commission on neuroimaging of the international league against epilepsy. Epilepsia 1998;39:1375-1376.
15. Von Oertzen J, Urbach H, Jungbluth S, Kurthen M, Reuber M, Fernandez G, et al. Standard magnetic resonance imaging is inadequate for patients with refractory focal epilepsy. J Neurol Neurosurg Psychiatry 2002;73:643-647.
16. Knake S, Triantafyllou C, Wald LL, Wiggins G, Kirk GP, Larsson PG, et al. 3T phased array MRI improves the presurgical evaluation in focal epilepsies: A prospective study. Neurology 2005;65:1026-1031.
17. Bronen RA, Fulbright RK, Kim JH, Spencer SS, Spencer DD. A systematic approach for interpreting MR images of the seizure patient. AJR Am J Roentgenol 1997;169: 241-247.
18. Jackson GD, Berkovic SF, Tress BM, Kalnins RM, Fabinyi GC, Bladin PF. Hippocampal sclerosis can be reliably detected by magnetic resonance imaging. Neurology 1990;40:1869-1875.
19. Oppenheim C, Dormont D, Biondi A, Lehericy S, Hasboun D, Clemenceau S, et al. Loss of digitations of the hippocampal head on high-resolution fast spin-echo MR: A sign of mesial temporal sclerosis. AJNR Am J Neuroradiol 1998;19:457-463.
20. Diehl B. CT scan and MRI in the definition of the epileptogenic lesion. In: Rosenow F, Luders H, editors. Presurgical assessment of the epilepsies with clinical neurophysiology and functional imaging. Handbook of Clinical Neurophysiology ed. Elsevier; 2004;199-216.
21. Liu RS, Lemieux L, Bell GS, Sisodiya SM, Shorvon SD, Sander JW, et al. A longitudinal study of brain morphometrics using quantitative magnetic resonance imaging and difference image analysis. NeuroImage 2003;20:22-33.
22. Liu RS, Lemieux L, Bell GS, Sisodiya SM, Bartlett PA, Shorvon SD, et al. Cerebral damage in epilepsy: A population-based longitudinal quantitative MRI study. Epilepsia 2005;46:1482-1494.
23. Duncan JS. Imaging and epilepsy. Brain 1997;120(Pt 2):339-377.
24. von Oertzen J, Urbach H, Blumcke I, Reuber M, Traber F, Peveling T, et al. Time-efficient T2 relaxometry of the entire hippocampus is feasible in temporal lobe epilepsy. Neurology 2002;58:257-264.
25. Widdess-Walsh P, Diehl B, Najm I. Neuroimaging of focal cortical dysplasia. J Neuroimaging 2006;16:185-196.
26. Diehl B, Symms MR, Boulby PA, Salmenpera T, Wheeler-Kingshott CA, Barker GJ, et al. Postictal diffusion tensor imaging. Epilepsy Res 2005;65:137-146.
27. Thivard L, Lehericy S, Krainik A, Adam C, Dormont D, Chiras J, et al. Diffusion tensor imaging in medial temporal lobe epilepsy with hippocampal sclerosis. Neuroimage 2005;28:682-690.
28. Wehner T, Lapresto E, Tkach J, Liu P, Bingaman W, Prayson RA, et al. The value of interictal diffusion-weighted imaging in lateralizing temporal lobe epilepsy. Neurology 2007;68:122-127.
29. Woo CL, Chuang SH, Becker LE, Jay V, Otsubo H, Rutka JT, et al. Radiologic-pathologic correlation in focal cortical dysplasia and hemimegalencephaly in 18 children. Pediatr Neurol 2001;25:295-303.
30. Salamon N, Andres M, Chute DJ, Nguyen ST, Chang JW, Huynh MN, et al. Contralateral hemimicrencephaly and clinical-pathological correlations in children with hemimegalencephaly. Brain 2006;129:352-365.
31. Guerrini R, Sicca F, Parmeggiani L. Epilepsy and malformations of the cerebral cortex. Epileptic Disord 2003;5;Suppl 2:S9-S26.
32. Sisodiya SM. Surgery for malformations of cortical development causing epilepsy. Brain 2000;123:1075-1091.
33. Janszky J, Ebner A, Kruse B, Mertens M, Jokeit H, Seitz RJ, et al. Functional organization of the brain with malformations of cortical development. Ann Neurol 2003;53:759-767.
34. Tassi L, Colombo N, Cossu M, Mai R, Francione S, Lo Russo G, et al. Electroclinical, MRI and neuro-pathological study of 10 patients with nodular heterotopia, with surgical outcomes. Brain 2005;128:321-337.
35. Chapman K, Wyllie E, Najm I, Ruggieri P, Bingaman W, Luders J, et al. Seizure outcome after epilepsy surgery in patients with normal preoperative MRI. J Neurol Neurosurg Psychiatry 2005;76:710-713.
36. Ruggieri PM, Najm I, Bronen R, Campos M, Cendes F, Duncan JS, et al. Neuroimaging of the cortical dysplasias. Neurology 2004;62:S27-S29.
37. Colliot O, Mansi T, Bernasconi N, Naessens V, Klironomos D, Bernasconi A. Segmentation of focal cortical dysplasia lesions on MRI using level set evolution. Neuroimage 2006;32:1621-1630.
38. Colliot O, Antel SB, Naessens VB, Bernasconi N, Bernasconi A. In vivo profiling of focal cortical dysplasia on high-resolution MRI with computational models. Epilepsia 2006;47:134-142.
39. Palmini A, Najm I, Avanzini G, Babb T, Guerrini R, Foldvary-Schaefer N, et al. Terminology and classification of the cortical dysplasias. Neurology 2004;62:S2-S8.
40. Colombo N, Tassi L, Galli C, Citterio A, Lo Russo G, Scialfa G, et al. Focal corticaldysplasias: MR imaging, histopathologic, and clinical correlations in surgically treated patients with epilepsy. AJNR Am J Neuroradiol 2003;24:724-733.
41. Widdess-Walsh P, Kellinghaus C, Jeha L, Kotagal P, Prayson R, Bingaman W, et al. Electro-clinical and imaging characteristics of focal cortical dysplasia: Correlation with pathological subtypes. Epilepsy Res 2005;67: 25-33.
42. Marusic P, Najm IM, Ying Z, Prayson R, Rona S, Nair D, et al. Focal cortical dysplasias in eloquent cortex: Functional characteristics and correlation with MRI and histopathologic changes. Epilepsia 2002;43: 27-32.
43. Bernasconi A. Advanced MRI analysis methods for detection of focal cortical dysplasia. Epileptic Disord 2003;5;Suppl 2:S81-S84.
44. Osborn AG, et al. Diagnostic imaging: Brain. Salt Lake City: Amirsys; 2004.
45. Baumann CR, Schuknecht B, Lo Russo G, Cossu M, Citterio A, Andermann F, et al. Seizure outcome after resection of cavernous malformations is better when surrounding hemosiderin-stained brain also is removed. Epilepsia 2006;47:563-566.
46. Ferroli P, Casazza M, Marras C, Mendola C, Franzini A, Broggi G. Cerebral cavernomas and seizures: A retrospective study on 163 patients who underwent pure lesionectomy. Neurol Sci 2006;26:390-394.
47. Cohen DS, Zubay GP, Goodman RR. Seizure outcome after lesionectomy for cavernous malformations. J Neurosurg 1995;83:237-242.
48. Cappabianca P, Alfieri A, Maiuri F, Mariniello G, Cirillo S, de Divitiis E. Supratentorial cavernous malformations and epilepsy: Seizure outcome after lesionectomy on a series of 35 patients. Clin Neurol Neurosurg 1997; 99:179-183.
49. Hammen T, Romstock J, Dorfler A, Kerling F, Buchfelder M, Stefan H. Prediction of postoperative outcome with special respect to removal of hemosiderin fringe: A study in patients with cavernous haemangiomas associated with symptomatic epilepsy. Seizure 2007;16: 248-253.
50. Maehara T, Nariai T, Arai N, Kawai K, Shimizu H, Ishii K, et al. Usefulness of [11C]methionine PET in the diagnosis of dysembryoplastic neuroepithelial tumor with temporal lobe epilepsy. Epilepsia 2004;45:41-45.
51. Rosenberg DS, Demarquay G, Jouvet A, Le Bars D, Streichenberger N, Sindou M, et al. [11C]-methionine PET: Dysembryoplastic neuroepithelial tumours compared with other epileptogenic brain neoplasms. J Neurol Neurosurg Psychiatry 2005;76:1686-1692.
52. Richardson MP, Hammers A, Brooks DJ, Duncan JS. Benzodiazepine-GABA(A) receptor binding is very low in dysembryoplastic neuroepithelial tumor: A PET study. Epilepsia 2001;42:1327-1334.
53. Prayson RA, Estes ML, Morris HH. Coexistence of neoplasia and cortical dysplasia in patients presenting with seizures. Epilepsia 1993;34:609-615.
54. Ferreira FT, Kobayashi E, Lopes-Cendes I, Cendes F. Structural abnormalities are similar in familial and nonfamilial mesial temporal lobe epilepsy. Can J Neurol Sci 2004;31:368-372.
55. Valenti MP, Froelich S, Armspach JP, Chenard MP, Dietemann JL, Kerhli P, et al. Contribution of SISCOM imaging in the presurgical evaluation of temporal lobe epilepsy related to dysembryoplastic neuroepithelial tumors. Epilepsia 2002;43:270-276.
56. Bautista JF, Foldvary-Schaefer N, Bingaman WE, Luders HO. Focal cortical dysplasia and intractable epilepsy in adults: Clinical, EEG, imaging, and surgical features. Epilepsy Res 2003;55:131-136.
57. Fauser S, Schulze-Bonhage A, Honegger J, Carmona H, Huppertz HJ, Pantazis G, et al. Focal cortical dysplasias: Surgical outcome in 67 patients in relation to histological subtypes and dual pathology. Brain 2004;127:2406-2418.
58. Bernasconi A. Quantitative MR imaging of the neocortex. Neuroimaging Clin N Am 2004;14:425-436.
59. Ashburner J, Friston KJ. Voxel-based morphometry--the methods. Neuroimage 2000;11:805-821.
60. Keller SS, Wilke M, Wieshmann UC, Sluming VA, Roberts N. Comparison of standard and optimized voxel-based morphometry for analysis of brain changes associated with temporal lobe epilepsy. Neuroimage 2004;23:860-868.
61. Bernasconi N, Duchesne S, Janke A, Lerch J, Collins DL, Bernasconi A. Whole-brain voxel-based statistical analysis of gray matter and white matter in temporal lobe epilepsy. Neuroimage 2004;23:717-723.
62. Bernasconi N, Bernasconi A, Caramanos Z, Antel SB, Andermann F, Arnold DL. Mesial temporal damage in temporal lobe epilepsy: A volumetric MRI study of the hippocampus, amygdala and parahippocampal region. Brain 2003;126:462-469.
63. Mueller SG, Laxer KD, Cashdollar N, Buckley S, Paul C, Weiner MW. Voxel-based optimized morphometry (VBM) of gray and white matter in temporal lobe epilepsy (TLE) with and without mesial temporal sclerosis. Epilepsia 2006;47:900-907.
64. Colliot O, Bernasconi N, Khalili N, Antel SB, Naessens V, Bernasconi A. Individual voxel-based analysis of gray matter in focal cortical dysplasia. Neuroimage 2006;29: 162-171.
65. Bonilha L, Montenegro MA, Rorden C, Castellano G, Guerreiro MM, Cendes F, et al. Voxel-based morphometry reveals excess gray matter concentration in patients with focal cortical dysplasia. Epilepsia 2006;47:908-915.
66. Rugg-Gunn FJ, Boulby PA, Symms MR, Barker GJ, Duncan JS. Whole-brain T2 mapping demonstrates occult abnormalities in focal epilepsy. Neurology 2005;64:318-325.
67. Salmenpera TM, Symms MR, Rugg-Gunn FJ, Boulby PA, Free SL, Barker GJ, et al. Evaluation of quantitative magnetic resonance imaging contrasts in MRI-negative refractory focal epilepsy. Epilepsia 2007;48: 229-237.
68. Won HJ, Chang KH, Cheon JE, Kim HD, Lee DS, Han MH, et al. Comparison of MR imaging with PET and ictal SPECT in 118 patients with intractable epilepsy. AJNR Am J Neuroradiol 1999;20:593-599.
69. Gaillard WD. Metabolic and functional imaging. In: Wyllie E, Gupta A, Lachhwani D, ed. The treatment of epilepsy. 4th ed. Philadelphia: Lippincott Williams &Wilkins 2006:1041-1058.
70. Choi JY, Kim SJ, Hong SB, Seo DW, Hong SC, Kim BT, et al. Extratemporal hypometabolism on FDG PET intemporal lobe epilepsy as a predictor of seizure outcome after temporal lobectomy. Eur J Nucl Med Mol Imaging 2003;30:581-587.
71. Vinton AB, Carne R, Hicks RJ, Desmond PM, Kilpatrick C, Kaye AH, et al. The extent of resection of FDG-PET hypometabolism relates to outcome of temporal lobectomy. Brain 2007;130:548-560.
72. Carne RP, O'Brien TJ, Kilpatrick CJ, MacGregor LR, Hicks RJ, Murphy MA, et al. MRI-negative PET-positive temporal lobe epilepsy: A distinct surgically remediable syndrome. Brain 2004;127:2276-2285.
73. Koepp MJ, Hammers A, Labbe C, Woermann FG, Brooks DJ, Duncan JS. 11C-flumazenil PET in patients with refractory temporal lobe epilepsy and normal MRI. Neurology 2000;54:332-339.
74. Hammers A, Koepp MJ, Richardson MP, Hurlemann R, Brooks DJ, Duncan JS. Grey and white matter flumazenil binding in neocortical epilepsy with normal MRI. A PET study of 44 patients. Brain 2003;126:1300-1318.
75. Hammers A, Koepp MJ, Brooks DJ, Duncan JS. Periventricular white matter flumazenil binding and postoperative outcome in hippocampal sclerosis. Epilepsia 2005;46:944-948.
76. Yun CH, Lee SK, Lee SY, Kim KK, Jeong SW, Chung CK. Prognostic factors in neocortical epilepsy surgery: Multivariate analysis. Epilepsia 2006;47:574-579.
77. Lee SK, Lee SY, Kim KK, Hong KS, Lee DS, Chung CK. Surgical outcome and prognostic factors of crypto-genic neocortical epilepsy. Ann Neurol 2005;58:525-532.
78. Van Paesschen W. Ictal SPECT. Epilepsia 2004;45;Suppl 4:S35-S40.
79. O'Brien TJ, So EL, Mullan BP, Hauser MF, Brinkmann BH, Bohnen NI, et al. Subtraction ictal SPECT co-registered to MRI improves clinical usefulness of SPECT in localizing the surgical seizure focus. Neurology 1998;50:445-454.
80. Lee SK, Lee SY, Yun CH, Lee HY, Lee JS, Lee DS. Ictal SPECT in neocortical epilepsies: Clinical usefulness and factors affecting the pattern of hyperperfusion. Neuroradiology 2006;48:678-684.
81. O'Brien TJ, So EL, Mullan BP, Cascino GD, Hauser MF, Brinkmann BH, et al. Subtraction peri-ictal SPECT is predictive of extratemporal epilepsy surgery outcome. Neurology 2000;55:1668-1677.
82. O'Brien TJ, So EL, Cascino GD, Hauser MF, Marsh WR, Meyer FB, et al. Subtraction SPECT coregistered to MRI in focal malformations of cortical development: Localization of the epileptogenic zone in epilepsy surgery candidates. Epilepsia 2004;45:367-376.
83. Dupont P, Van Paesschen W, Palmini A, Ambayi R, Van Loon J, Goffin J, et al. Ictal perfusion patterns associated with single MRI-visible focal dysplastic lesions: Implications for the noninvasive delineation of the epileptogenic zone. Epilepsia 2006;47:1550-1557.
84. Medina LS, Bernal B, Dunoyer C, Cervantes L, Rodriguez M, Pacheco E, et al. Seizure disorders: Functional MR imaging for diagnostic evaluation and surgical treatment--prospective study. Radiology 2005;236:247-253.
85. Jack CR, Thompson RM, Butts RK, Sharbrough FW, Kelly PJ, Hanson DP, et al. Sensory motor cortex: Correlation of presurgical mapping with functional MR imaging and invasive cortical mapping. Radiology 1994; 190:85-92.
86. Puce A, Constable RT, Luby ML, McCarthy G, Nobre AC, Spencer DD, et al. Functional magnetic resonance imaging of sensory and motor cortex: Comparison with electrophysiological localization. J Neurosurg 1995;83: 262-270.
87. Lehericy S, Duffau H, Cornu P, Capelle L, Pidoux B, Carpentier A, et al. Correspondence between functional magnetic resonance imaging somatotopy and individual brain anatomy of the central region: Comparison with intra-operative stimulation in patients with brain tumors. J Neurosurg 2000;92:589-598.
88. Yetkin FZ, Mueller WM, Morris GL, McAuliffe TL, Ulmer JL, Cox RW, et al. Functional MR activation correlated with intraoperative cortical mapping. AJNR Am J Neuroradiol 1997;18:1311-1315.
89. Rabin ML, Narayan VM, Kimberg DY, Casasanto DJ, Glosser G, Tracy JI, et al. Functional MRI predicts post-surgical memory following temporal lobectomy. Brain 2004;127:2286-2298.
90. Richardson MP, Strange BA, Thompson PJ, Baxendale SA, Duncan JS, Dolan RJ. Pre-operative verbal memory fMRI predicts post-operative memory decline after left temporal lobe resection. Brain 2004;127:2419-2426.
91. Richardson MP, Strange BA, Duncan JS, Dolan RJ. Memory fMRI in left hippocampal sclerosis: Optimizing the approach to predicting postsurgical memory. Neurology 2006;66:699-705.
92. Janszky J, Jokeit H, Kontopoulou K, Mertens M, Ebner A, Pohlmann-Eden B, et al. Functional MRI predicts memory performance after right mesiotemporal epilepsy surgery. Epilepsia 2005;46:244-250.
93. Lehericy S, Cohen L, Bazin B, Samson S, Giacomini E, Rougetet R, et al. Functional MR evaluation of temporal and frontal language dominance compared with the wada test. Neurology 2000;54:1625-1633.
94. FitzGerald DB, Cosgrove GR, Ronner S, Jiang H, Buchbinder BR, Belliveau JW, et al. Location of language in the cortex: A comparison between functional MR imaging and electrocortical stimulation. AJNR Am J Neuroradiol 1997;18:1529-1539.